Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.
Adipose-derived stem cell therapy is a field of regenerative medicine that draws significant interest for its potential to support the body’s natural repair processes. However, for many considering this option, the practical steps involved—specifically fat collection and IV infusion—can be a source of anxiety. Understanding what these procedures entail is the first step toward making an informed decision. This article aims to address common questions and concerns to help you feel more prepared for your consultation.
Understanding Common Patient Concerns
When considering a new medical treatment, it’s natural to have questions. For adipose-derived stem cell therapy, patient anxieties often center on the two main physical procedures:
- The Fat Collection Procedure: Will it be painful? How long will it take? What is recovery like?
- The Stem Cell IV Infusion: What does it feel like? Are there immediate side effects? How much time does it require?
By breaking down each step, we can demystify the process and provide a clearer picture of the patient experience.
A Closer Look at the Fat Collection Procedure
The first major step is collecting a small amount of adipose (fat) tissue, from which mesenchymal stem cells (MSCs) will be isolated and cultured. This is a minor procedure performed on an outpatient basis.
- Pain Management: The collection is performed under local anesthesia. This means the area, typically the abdomen or buttocks, is numbed. While you may feel some pressure or movement, significant pain is generally managed by the anesthetic. The sensation is often described as minimal.
- Procedure Duration: The collection itself is typically a short process, often completed in under an hour. A very small incision is made, and only a tiny amount of fat tissue—sometimes just a few rice-grain-sized pieces—is needed.
- Post-Procedure Sensation: After the anesthesia wears off, you might experience mild soreness, bruising, or swelling at the collection site, similar to a minor bump. These effects are usually temporary and resolve within a few days. Most patients can return to their daily activities shortly after the procedure, with guidance from their physician on strenuous exercise.
The Stem Cell IV Infusion Process
After the collected stem cells are cultured and expanded at a specialized facility—a process that takes several weeks—they are returned to your body through a simple intravenous (IV) infusion. This step is also performed on an outpatient basis.
- The Experience: The infusion is very similar to receiving a standard IV drip. A small needle is inserted into a vein in your arm, and the solution containing your cultured stem cells is slowly administered. The process is generally not painful, apart from the initial brief prick of the needle.
- Treatment Duration: The infusion itself usually takes about one to two hours, during which you can relax comfortably.
- After the Infusion: There is typically no downtime required after the infusion. Patients can usually resume their normal activities immediately. It is reported that infused MSCs can travel through the bloodstream and accumulate at sites of inflammation or damage, a phenomenon known as the “homing effect,” to support tissue repair.
Important Considerations and Questions for Your Doctor
While the procedures are generally well-tolerated, adipose-derived stem cell therapy is a sophisticated medical treatment that requires careful consideration. It is crucial to have a thorough discussion with a physician to determine if it is a suitable option for you.
This treatment is provided as a non-insured, private medical service (free practice). In Japan, it is offered under a treatment plan submitted to and accepted by the Ministry of Health, Labour and Welfare, in accordance with the Act on the Safety of Regenerative Medicine. A physician’s diagnosis is essential to determine eligibility.
Before proceeding, be sure to ask your doctor:
- Am I a suitable candidate for this therapy based on my health condition?
- What are the potential risks and side effects associated with the procedure?
- What is the estimated total cost, duration, and number of treatments?
- What outcomes might be realistically expected in my case?
Learn More at Grand Green Osaka Umekita Clinic
At Grand Green Osaka Umekita Clinic, we believe that patient education is key to a positive treatment experience. Our team is available to answer your questions and provide a comprehensive overview of adipose-derived stem cell therapy. We prioritize a thorough consultation to ensure you have all the information needed to make a decision that aligns with your health goals.
For detailed information on our treatment flow, fees, and potential risks and side effects, please visit our dedicated regenerative medicine page. We offer multilingual support for international patients seeking care in Osaka, Japan.
Learn more about Adipose-Derived Stem Cell Therapy
Conclusion: Informed Decisions Lead to Better Experiences
The thought of undergoing any medical procedure can be daunting, but understanding the steps involved can significantly alleviate anxiety. Both the fat collection and IV infusion for adipose-derived stem cell therapy are typically straightforward, outpatient procedures with manageable recovery. The most important step is a comprehensive consultation with a qualified physician to discuss your individual circumstances, the potential benefits, and the associated risks. Taking the time to gather accurate information is essential for a confident and comfortable treatment journey.
- 11. ConsultationDiscuss your condition with a doctor
- 22. Fat Tissue CollectionMinor outpatient procedure
- 33. Cell Culture & ExpansionTakes several weeks at a facility
- 44. Stem Cell IV InfusionA simple 1-2 hour IV drip
- 55. Return to Daily LifeNo downtime after infusion
This is a conceptual diagram to summarize the content of the article
References
- PMC: Off-label use of adipose-derived stem cells. (2017)
- PMC: Co-administration of human adipose-derived stem cells and low-level laser to alleviate neuropathic pain after experimental spinal cord injury. (2019)
- PMC: Autologous Stromal Vascular Fraction in the Intravenous Treatment of End-Stage Chronic Obstructive Pulmonary Disease: A Phase I Trial of Safety and Tolerability. (2017)
- PMC: In Vitro Cultures of Adipose-Derived Stem Cells: An Overview of Methods, Molecular Analyses, and Clinical Applications. (2020)
- MHLW (Japan): Regenerative Medicine — Ministry of Health, Labour and Welfare, Japan
Supervising Physician
Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic
Hidenori Shimada
Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.
* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.